Intellipharmaceutics International Inc. Quarterly Liabilities in USD from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Intellipharmaceutics International Inc. quarterly Liabilities history and growth rate from Q4 2010 to Q1 2023.
  • Intellipharmaceutics International Inc. Liabilities for the quarter ending February 28, 2023 was $12.5M, a 14.9% increase year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $12.5M +$1.62M +14.9% Feb 28, 2023 6-K 2023-09-26
Q4 2022 $12M +$1.76M +17.1% Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $11.6M +$1.96M +20.4% Aug 31, 2022 6-K 2022-10-14
Q2 2022 $11.7M +$1.73M +17.3% May 31, 2022 6-K 2022-07-21
Q1 2022 $10.9M Feb 28, 2022 6-K 2022-04-14
Q4 2021 $10.3M +$551K +5.68% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $9.62M +$723K +8.12% Aug 31, 2021 6-K 2021-10-15
Q2 2021 $10M +$636K +6.79% May 31, 2021 6-K 2021-07-15
Q4 2020 $9.7M +$2.21M +29.5% Nov 30, 2020 20-F/A 2022-05-09
Q3 2020 $8.9M +$2.33M +35.5% Aug 31, 2020 6-K 2020-10-15
Q2 2020 $9.37M +$2.8M +42.6% May 31, 2020 6-K 2020-07-15
Q1 2020 $8.44M +$1.79M +27% Feb 29, 2020 6-K 2020-05-29
Q4 2019 $7.49M +$117K +1.59% Nov 30, 2019 6-K 2020-10-15
Q3 2019 $6.57M -$4.02M -38% Aug 31, 2019 6-K 2019-10-11
Q2 2019 $6.57M -$1.13M -14.6% May 31, 2019 6-K 2019-07-10
Q1 2019 $6.65M Feb 28, 2019 6-K 2019-04-15
Q4 2018 $7.37M +$362K +5.16% Nov 30, 2018 20-F 2020-03-30
Q3 2018 $10.6M Aug 31, 2018 6-K 2018-10-15
Q2 2018 $7.7M May 31, 2018 6-K/A 2018-07-24
Q4 2017 $7.01M Nov 30, 2017 6-K 2018-10-15
Q4 2015 $5.36M +$2.4M +80.8% Nov 30, 2015 20-F 2016-03-21
Q4 2014 $2.97M -$7.37M -71.3% Nov 30, 2014 20-F 2016-03-21
Q1 2014 $3.56M Feb 28, 2014 6-K 2014-04-14
Q4 2013 $10.3M +$6.09M +144% Nov 30, 2013 20-F 2015-02-27
Q4 2012 $4.24M -$5.1M -54.6% Nov 30, 2012 20-F 2014-02-18
Q4 2011 $9.34M +$6.17M +194% Nov 30, 2011 20-F/A 2013-02-01
Q4 2010 $3.17M Nov 30, 2010 20-F 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.